CLOs on the Move

Motus GI

www.motusgi.com

 
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.motusgi.com
  • 1301 E. Broward Blvd. Suite 310
    Fort Lauderdale, FL USA 33301
  • Phone: 954.541.8000

Executives

Name Title Contact Details

Similar Companies

MyLife Franchise Corporation

MyLife Franchise Corporation is a Portsmouth, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CanadaDrugs.com LP

CanadaDrugs.com LP is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Neocis

Neocis is transforming dental implant surgery with advanced robotics. The company is focused on enhancing dental surgeons` capabilities and advancing patient care through the latest technology.

Next Step Orthotics

Next Step Orthotics is a Manchester, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.